These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12718751)

  • 1. Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis.
    Newkirk MM; Goldbach-Mansky R; Lee J; Hoxworth J; McCoy A; Yarboro C; Klippel J; El-Gabalawy HS
    Arthritis Res Ther; 2003; 5(2):R82-90. PubMed ID: 12718751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
    Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
    Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE.
    Ligier S; Fortin PR; Newkirk MM
    Br J Rheumatol; 1998 Dec; 37(12):1307-14. PubMed ID: 9973155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA).
    Newkirk MM; LePage K; Niwa T; Rubin L
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1129-38. PubMed ID: 9846895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
    Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
    Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The isotype repertoire of antibodies against novel UH-RA peptides in rheumatoid arthritis.
    De Winter LM; Geusens P; Lenaerts J; Vanhoof J; Stinissen P; Somers V
    Arthritis Res Ther; 2016 Jun; 18(1):130. PubMed ID: 27267896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis.
    Lucey MD; Newkirk MM; Neville C; Lepage K; Fortin PR
    J Rheumatol; 2000 Feb; 27(2):319-23. PubMed ID: 10685791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential recognition of epitopes on AGE-IgG by the autoantibodies in rheumatoid arthritis patients.
    Ahmad S; Habib S; Moinuddin ; Ali A
    Hum Immunol; 2013 Jan; 74(1):23-7. PubMed ID: 23073292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG Subclass Specificity Discriminates Restricted IgM Rheumatoid Factor Responses From More Mature Anti-Citrullinated Protein Antibody-Associated or Isotype-Switched IgA Responses.
    Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Wolbink G; Rispens T
    Arthritis Rheumatol; 2015 Dec; 67(12):3124-34. PubMed ID: 26246004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.
    Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S
    Scand J Rheumatol; 2011 Nov; 40(6):422-7. PubMed ID: 22150462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass.
    Cambridge G; Williams M; Leaker B; Corbett M; Smith CR
    Ann Rheum Dis; 1994 Jan; 53(1):24-9. PubMed ID: 8311550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of IgM-, IgA- and IgG-rheumatoid factors in seronegative polyarticular disease compared to pauciarticular disease in juvenile chronic arthritis as measured by ELISA.
    Varbanova BB; Baleva M; Nikolov K; Mihailova D
    Adv Exp Med Biol; 1999; 455():61-8. PubMed ID: 10599324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.
    Vencovský J; Machácek S; Sedová L; Kafková J; Gatterová J; Pesáková V; Růzicková S
    Ann Rheum Dis; 2003 May; 62(5):427-30. PubMed ID: 12695154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
    Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
    Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of IgM-rheumatoid factor and anti-citrullinated protein antibodies in healthy horses and their comparison.
    Hoikhman R; Kudlackova H; Babak V; Faldyna M; Jahn P
    Vet Immunol Immunopathol; 2018 Aug; 202():141-146. PubMed ID: 30078588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
    Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
    Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.